Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,415 | -9,516 | -288 | -7,810 | -4,687 |
| Depreciation Amortization | 7,278 | 7,855 | 7,901 | 8,812 | 8,118 |
| Income taxes - deferred | 336 | -414 | -330 | -23 | -398 |
| Accounts receivable | 810 | 4,780 | -4,294 | 3,105 | 468 |
| Accounts payable and accrued liabilities | 555 | -1,399 | 2,454 | 1,491 | -2,048 |
| Other Working Capital | 4,600 | 2,716 | -10,190 | 4,106 | 42 |
| Other Operating Activity | 3,864 | -2,870 | 6,009 | -350 | 6,550 |
| Operating Cash Flow | $14,028 | $1,152 | $1,262 | $9,331 | $8,045 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,276 | -1,590 | -1,195 | -1,152 | -1,216 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 1,002 |
| Purchase Sale Intangibles | -523 | N/A | -150 | -250 | N/A |
| Other Investing Activity | -523 | 0 | -150 | -250 | -15 |
| Investing Cash Flow | $-1,799 | $-1,590 | $-1,345 | $-1,402 | $-229 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,500 | 7,800 | 4,250 | 61,315 | 4,300 |
| Debt Repayment | -15,041 | -9,586 | -4,200 | -66,912 | -11,703 |
| Common Stock Issued | 930 | 577 | 3,314 | 669 | -221 |
| Other Financing Activity | -2,523 | -1,628 | -3,616 | -3,039 | 0 |
| Financing Cash Flow | $-12,134 | $-2,837 | $-252 | $-7,967 | $-7,624 |
| Exchange Rate Effect | -320 | -38 | -161 | 20 | -30 |
| Beginning Cash Position | 4,508 | 7,821 | 8,317 | 8,335 | 8,173 |
| End Cash Position | 4,283 | 4,508 | 7,821 | 8,317 | 8,335 |
| Net Cash Flow | $-225 | $-3,313 | $-496 | $-18 | $162 |
| Free Cash Flow | |||||
| Operating Cash Flow | 14,028 | 1,152 | 1,262 | 9,331 | 8,045 |
| Capital Expenditure | -1,788 | -1,590 | -1,195 | -1,152 | -1,216 |
| Free Cash Flow | 12,240 | -438 | 67 | 8,179 | 6,829 |